News
News releases on November 5, 2024, page 7
Every news release public companies put out on November 5, 2024 (UTC): 828 news releases, newest first. Open any release to read it.
Gogo Announces Third Quarter Results
Gogo Inc. · Nov 5, 2024
GlobalFoundries Reports Third Quarter 2024 Financial Results
GlobalFoundries Inc. · Nov 5, 2024
Global-e to Announce Financial Results for the Third Quarter 2024 on November 20, 2024
Global-E Online Ltd. · Nov 5, 2024
Geron Announces New Data to be Presented at Upcoming ASH Annual Meeting Highlighting the Potential of RYTELO™ (imetelstat) in Myeloid Hem...
Geron Corporation · Nov 5, 2024
GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024
GeoVax Labs, Inc. · Nov 5, 2024
Geologica Resource Updates Terms to Unit Financing
Geologica Resource Corp. · Nov 5, 2024
Gentex to Host Three Vehicle Unveils and Showcase Technology for Automotive OEMs, Race Teams, and the Aftermarket at SEMA 2024
Gentex Corporation · Nov 5, 2024
Gaxos to Participate in The AI Summit New York on December 11th to December 12th in New York City
Gaxos.ai Inc. · Nov 5, 2024
Forrester Research Reports 2024 Third-Quarter Financial Results
Forrester Research, Inc. · Nov 5, 2024
Forian Inc. to Announce Third Quarter 2024 Results on November 13, 2024
Forian Inc. · Nov 5, 2024
Forge Resources Announces Start of Construction on Mine Portal and Upcoming Executive Site Visit at Fully Permitted Coal Project, Colombia
Forge Resources Corp. · Nov 5, 2024
Fluence Energy, Inc. Announces Fourth Quarter and Fiscal Year 2024 Earnings Release Date, Conference Call and Webcast
Fluence Energy, Inc. · Nov 5, 2024
Exploits Discovery Announces Non-Brokered Charity Flow Through Financing with Strategic Investor and Flow Through Share Private Placement
Epic Gold Corp. · Nov 5, 2024
European Wax Center, Inc. to Report Third Quarter Fiscal Year 2024 Financial Results on November 14th
European Wax Center, Inc. · Nov 5, 2024
Ero Copper Reports Third Quarter 2024 Operating and Financial Results
Ero Copper Corp. · Nov 5, 2024
Ero Copper Announces Leadership Succession: David Strang to Become Executive Chairman, Makko DeFilippo to be Appointed President & CEO
Ero Copper Corp. · Nov 5, 2024
Erasca to Present at Upcoming Investor Conferences
Erasca, Inc. · Nov 5, 2024
Eos Energy Signs Agreement with City Utilities of Springfield, Missouri to Provide 216 MWh of Energy Storage
Eos Energy Enterprises, Inc. · Nov 5, 2024
Eos Energy Enterprises Reports Third Quarter 2024 Financial Results and Updates 2024 Outlook
Eos Energy Enterprises, Inc. · Nov 5, 2024
Entrada Therapeutics Reports Third Quarter 2024 Financial Results
Entrada Therapeutics, Inc. · Nov 5, 2024
Enovix Completes $100 Million Equity Offering
Enovix Corporation · Nov 5, 2024
enGene to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference
enGene Therapeutics Inc. · Nov 5, 2024
Endeavour Silver Announces Q3 2024 Financial Results; Earnings Call at 10AM PDT (1PM EDT) Today
Endeavour Silver Corp. · Nov 5, 2024
eGain to Announce Fiscal 2025 First Quarter Financial Results on November 12, 2024
eGain Corporation · Nov 5, 2024
Eastside Utility District to Modernize Water Network in Tennessee with Itron’s Smart Water Solution
Itron, Inc. · Nov 5, 2024
Eastside Distilling, Inc. to Report 2024 Third Quarter Results on Thursday, November 14, 2024
Beeline Holdings, Inc. · Nov 5, 2024
Dundee Precious Metals Announces 2024 Third Quarter Results; Continuing Track Record of Strong Free Cash Flow Generation
DPM Metals Inc. · Nov 5, 2024
DLH to Provide Critical Systems Engineering and Integrated Logistics Services for Navy C5ISR Systems
DLH Holdings Corp. · Nov 5, 2024
Distribution Solutions Group to Participate in Two Conferences: Baird 2024 Global Industrial Conference & Stephens Annual Investment Conf...
Distribution Solutions Group, Inc. · Nov 5, 2024
Disc Medicine Announces Multiple Presentations Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting
Disc Medicine, Inc. · Nov 5, 2024
Defense Logistics Agency Selects Tetra Tech for Its $12 Billion Enterprise Technology Services Multiple-Award Contract
Tetra Tech, Inc. · Nov 5, 2024
Dave Announces Preliminary Financial Results for Third Quarter 2024 and Issues Statement Regarding FTC Matter
Dave Inc. · Nov 5, 2024
Data Storage Corporation Schedules Third Quarter 2024 Business Update Conference Call
Data Storage Corporation · Nov 5, 2024
Cytokinetics Announces Six Upcoming Presentations at the American Heart Association Scientific Sessions 2024
Cytokinetics, Incorporated · Nov 5, 2024
Cytek Biosciences Reports Third Quarter 2024 Financial Results
Cytek Biosciences, Inc. · Nov 5, 2024
CXApp Inc. (Nasdaq: CXAI) Schedules Third Quarter 2024 Financial Results and Business Update Conference Call
CXApp Inc. · Nov 5, 2024
Cullinan Therapeutics to Participate in Fireside Chat at Stifel 2024 Healthcare Conference
Cullinan Therapeutics, Inc. · Nov 5, 2024
Crown Crafts to Announce Second Quarter Fiscal Year 2025 Results on November 12, 2024
Crown Crafts, Inc. · Nov 5, 2024
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results
CRISPR Therapeutics AG · Nov 5, 2024
Cricut, Inc. Reports Third Quarter 2024 Financial Results
Cricut, Inc. · Nov 5, 2024
CRIANN boosts bandwidth in French research and education network with Adtran FSP 3000
ADTRAN Holdings, Inc. · Nov 5, 2024
CORRECTING and REPLACING CPI Card Group Inc. Reports Third Quarter 2024 Results
CPI Card Group Inc. · Nov 5, 2024
CORRECTING and REPLACING CoStar Group Calls for Entries Ahead of Fourth Annual CoStar Impact Awards
CoStar Group, Inc. · Nov 5, 2024
Core Scientific Announces October 2024 Production and Operations Updates
Core Scientific, Inc. · Nov 5, 2024
Consolidated Water Sets Third Quarter 2024 Investor Conference Call for Friday, November 15, 2024 at 11: 00 a.m. ET
Consolidated Water Co. Ltd. · Nov 5, 2024
Compugen to Present Anti-Tumor Activity and Safety Data of COM701, COM902 and Pembrolizumab Combination in Patients with Platinum Resista...
Compugen Ltd. · Nov 5, 2024
Complete Solar Announces Preliminary Q3’24 Results
SunPower Inc. · Nov 5, 2024
Cogent Biosciences Announces Bezuclastinib Presentations at the 66th Annual American Society of Hematology (ASH) Meeting
Cogent Biosciences, Inc. · Nov 5, 2024
Co-Diagnostics, Inc. to Host Booth at MEDICA Trade Fair in Düsseldorf, Germany on Nov 11-14, 2024
Co-Diagnostics, Inc. · Nov 5, 2024
Cineverse Appoints Rey Puentenegra as Vice President, Corporate Controller
Cineverse Corp. · Nov 5, 2024
Charter's Executive Vice President and Chief Commercial Officer Adam Ray to oversee Spectrum Enterprise
Charter Communications, Inc. · Nov 5, 2024
Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
Century Therapeutics, Inc. · Nov 5, 2024
Century Therapeutics Announces Upcoming Poster Presentations at the 2024 American Society of Hematology (ASH) Annual Meeting
Century Therapeutics, Inc. · Nov 5, 2024
Cenntro’s Avantier Motors Corporation Expands European Offerings with Launch of Avantier Ex and Avantier Commuter Electric Vehicles
Cenntro Inc. · Nov 5, 2024
Cathay Bank Foundation Announces the 2024 Scholarship Recipients, The Rising Stars of Our Communities
Cathay General Bancorp · Nov 5, 2024
Casey's Announces the Closing of the Fikes Wholesale Acquisition and Provides a Business Update
Caseys General Stores, Inc. · Nov 5, 2024
Cartesian Therapeutics Announces Presentation at the Upcoming 66th ASH Annual Meeting
Cartesian Therapeutics, Inc. · Nov 5, 2024
Carlyle Secured Lending, Inc. Announces Financial Results For Third Quarter Ended 2024, Declares Fourth Quarter 2024 Dividends of $0.45 P...
Carlyle Secured Lending, Inc. · Nov 5, 2024
Capricor Therapeutics to Present Third Quarter 2024 Financial Results and Recent Corporate Update on November 13
Capricor Therapeutics, Inc. · Nov 5, 2024
Capital Southwest Announces Pricing of Convertible Notes Offering
Capital Southwest Corporation · Nov 5, 2024
Candel Therapeutics to Present Preclinical Data at SITC Annual Meeting Showing Promise for CAN-3110 in Melanoma, Signaling Potential Indi...
Candel Therapeutics, Inc. · Nov 5, 2024
C4 Therapeutics to Present Data from the Ongoing Phase 1/2 Trial of Cemsidomide in Multiple Myeloma and Non-Hodgkin’s Lymphoma at the Ame...
C4 Therapeutics, Inc. · Nov 5, 2024
Bruker Reports Third Quarter 2024 Financial Results
Bruker Corporation · Nov 5, 2024
BridgeBio Announces Publication of Case Study Exploring Portfolio Theory’s Impact on Biomedical Innovation in The Journal of Portfolio Ma...
BridgeBio Pharma, Inc. · Nov 5, 2024
Blink to establish a £100 million Special Purpose Vehicle to Drive Electric Vehicle Charger Investments, Engaging Axxeltrova Capital as F...
Blink Charging Co. · Nov 5, 2024
Black Diamond Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Black Diamond Therapeutics, Inc. · Nov 5, 2024
BitFuFu Reports Unaudited Third Quarter 2024 Financial Results
BitFuFu Inc. · Nov 5, 2024
BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health
BioRestorative Therapies, Inc. · Nov 5, 2024
Beasley Broadcast Group Reports Third Quarter Revenue of $58.2 Million
Beasley Broadcast Group, Inc. · Nov 5, 2024
Beam Therapeutics Reports Third Quarter 2024 Financial Results and Progress Across Priority Programs
Beam Therapeutics Inc. · Nov 5, 2024
Beam Therapeutics to Present Data Across Hematology Franchise, Including First Clinical Data for BEAM-101 in Sickle Cell Disease and ESCA...
Beam Therapeutics Inc. · Nov 5, 2024
Aviat Networks Announces Fiscal 2025 First Quarter and Three Month Financial Results
Aviat Networks, Inc. · Nov 5, 2024
Atossa Therapeutics Appoints Claudia Lopez, DVM, MSc, as Vice President, Clinical Product Development
Atossa Therapeutics, Inc. · Nov 5, 2024
Atara Biotherapeutics to Announce Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
Atara Biotherapeutics, Inc. · Nov 5, 2024
Arteris Announces Financial Results for the Third Quarter 2024 and Fourth Quarter and Full Year 2024 Guidance
Arteris, Inc. · Nov 5, 2024
Artelo Biosciences Announces Acceptance of ART26.12 into the National Institutes of Health’s “Preclinical Screening Platform for Pain” Pr...
Artelo Biosciences, Inc. · Nov 5, 2024
Arrowhead Pharmaceuticals to Webcast 2024 Fiscal Year End Results
Arrowhead Pharmaceuticals, Inc. · Nov 5, 2024
Ardelyx to Participate at the 2024 Jefferies London Healthcare Conference
Ardelyx, Inc. · Nov 5, 2024
ARB IOT Group Limited Signs a Memorandum of Understanding (MOU) To Accelerate Global AI Revolution with Advanced Server Solutions
ARB IOT Group Limited · Nov 5, 2024
AquaBounty Technologies Announces Third Quarter 2024 Financial Results
AquaBounty Technologies, Inc. · Nov 5, 2024
Apellis Pharmaceuticals Reports Third Quarter 2024 Financial Results
Apellis Pharmaceuticals, Inc. · Nov 5, 2024
Antelope Enterprise Holdings Limited Receives Deficiency Letter from NASDAQ Regarding Minimum Bid Price Deficiency
Antelope Enterprise Holdings Limited · Nov 5, 2024
Anaptys Announces Third Quarter 2024 Financial Results and Provides Business Update
AnaptysBio, Inc. · Nov 5, 2024
Anaptys Announces Participation in November and December Investor Conferences
AnaptysBio, Inc. · Nov 5, 2024
AmeriServ Financial Inc. Completes Merger of Subsidiary Trust Company
AmeriServ Financial Inc. · Nov 5, 2024
America’s Car-Mart, Inc. Schedules Second Quarter Fiscal Year 2025 Results and Conference Call
America's Car-Mart, Inc. · Nov 5, 2024
American Resources Corporation’s ReElement Technologies Updates Progress On Marion Super Site For United States’ Largest Combined Rare Ea...
American Resources Corporation · Nov 5, 2024
American Rebel Supports Metro Nashville Police Department’s 30th Annual Toy Parade in collaboration with Boswell’s Harley-Davidson – Amer...
American Rebel Holdings, Inc. · Nov 5, 2024
Ambarella Announces Third Quarter Fiscal Year 2025 Earnings Conference Call to be Held November 26, 2024
Ambarella, Inc. · Nov 5, 2024
Allogene Therapeutics to Present New Data Demonstrating the Potential of ALLO-316 in Heavily Pretreated Adult Patients with CD70 Positive...
Allogene Therapeutics, Inc. · Nov 5, 2024
Aldebaran Resources Engages ICP Securities for Automated Market Making Services
Aldebaran Resources Inc · Nov 5, 2024
Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH Annual Meeting and Exposition
Agios Pharmaceuticals, Inc. · Nov 5, 2024
Agenus to Provide Third Quarter 2024 Financial Report and Corporate Update
Agenus Inc. · Nov 5, 2024
Aemetis Announces Support for Updated Low Carbon Fuel Standard and Encourages CARB Adoption on November 8th
Aemetis, Inc · Nov 5, 2024
Advanced Energy to Host Its 2024 Analyst Day and Participate at Upcoming Investor Conferences
Advanced Energy Industries, Inc. · Nov 5, 2024
Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer
Adial Pharmaceuticals, Inc · Nov 5, 2024
AdaptHealth Corp. Announces Third Quarter 2024 Results
AdaptHealth Corp. · Nov 5, 2024
AC Immune Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
AC Immune SA · Nov 5, 2024
Acadia Pharmaceuticals Enters Into an Agreement to Sell its Rare Pediatric Disease Priority Review Voucher for $150 Million
ACADIA Pharmaceuticals Inc. · Nov 5, 2024
Ghana Fund to Invest US$2.0M in Kambale Graphite Project
Castle Minerals Ltd · Nov 5, 2024